📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2 (2021)

First Author: Giulia Pellizzari

Attributed to: Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.60692/kn211-x3w26

Publication URI: https://gresis.osc.int//doi/10.60692/kn211-x3w26

Type: Other